Integrative transcriptomics analysis for uterine leiomyosarcoma identifies aberrant activation of cell cycle-dependent kinases and their potential therapeutic significance
View ORCID ProfileKosuke Yoshida, Akira Yokoi, Tomofumi Yamamoto, Yusuke Hayashi, Jun Nakayama, Tsuyoshi Yokoi, Hiroshi Yoshida, Tomoyasu Kato, Hiroaki Kajiyama, Yusuke Yamamoto
doi: https://doi.org/10.1101/2022.01.06.22268775
Kosuke Yoshida
1Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan
2Institute for Advanced Research, Nagoya University, Nagoya, Japan
3Laboratory of Integrative Oncology, National Cancer Center Research Institute, Tokyo, Japan
Akira Yokoi
1Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan
2Institute for Advanced Research, Nagoya University, Nagoya, Japan
Tomofumi Yamamoto
3Laboratory of Integrative Oncology, National Cancer Center Research Institute, Tokyo, Japan
Yusuke Hayashi
3Laboratory of Integrative Oncology, National Cancer Center Research Institute, Tokyo, Japan
Jun Nakayama
3Laboratory of Integrative Oncology, National Cancer Center Research Institute, Tokyo, Japan
Tsuyoshi Yokoi
4Department of Drug Safety Sciences, Division of Clinical Pharmacology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Hiroshi Yoshida
5Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan
Tomoyasu Kato
6Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan
Hiroaki Kajiyama
1Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Yusuke Yamamoto
3Laboratory of Integrative Oncology, National Cancer Center Research Institute, Tokyo, Japan
Data Availability
The data generated in this study are publicly available in Gene Expression Omnibus (GEO) at GSE185543.
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE185543
Posted January 07, 2022.
Integrative transcriptomics analysis for uterine leiomyosarcoma identifies aberrant activation of cell cycle-dependent kinases and their potential therapeutic significance
Kosuke Yoshida, Akira Yokoi, Tomofumi Yamamoto, Yusuke Hayashi, Jun Nakayama, Tsuyoshi Yokoi, Hiroshi Yoshida, Tomoyasu Kato, Hiroaki Kajiyama, Yusuke Yamamoto
medRxiv 2022.01.06.22268775; doi: https://doi.org/10.1101/2022.01.06.22268775
Integrative transcriptomics analysis for uterine leiomyosarcoma identifies aberrant activation of cell cycle-dependent kinases and their potential therapeutic significance
Kosuke Yoshida, Akira Yokoi, Tomofumi Yamamoto, Yusuke Hayashi, Jun Nakayama, Tsuyoshi Yokoi, Hiroshi Yoshida, Tomoyasu Kato, Hiroaki Kajiyama, Yusuke Yamamoto
medRxiv 2022.01.06.22268775; doi: https://doi.org/10.1101/2022.01.06.22268775
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2930)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12734)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4577)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (388)
- HIV/AIDS (924)
- Medical Education (424)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4344)
- Nursing (236)
- Nutrition (638)
- Oncology (2266)
- Ophthalmology (645)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (500)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6932)
- Radiology and Imaging (1526)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (487)
- Toxicology (60)
- Transplantation (210)
- Urology (180)